CTRI/2020/12/029928尚未招募未知
Evaluation of immunoexpression of galectin-3 in oral submucous fibrosis and healthy oral mucosa.
Dr Hetvi Sheth0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Clinically diagnosed cases of OSMF with or without malignant transformation.
排除标准
- •1. Patient who has undergone any kind of invasive treatment for OSMF before.
- •2. Patient with any systemic and infectious disease.
- •3. The patient who is not willing to participate in the study.
研究者
相似试验
已完成
不适用
Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patientson-small cell lung cancerJPRN-UMIN000026869Shiga University of Medical Science250
进行中（未招募）
不适用
se of galectin-3 as a blood marker for patients with Chagas disease.Chronic Chagas Disease with cardiac involvementB57.2RBR-5m6748Hospital São Rafael
已完成
不适用
Serum Galectin-3 in AFKCT0005496Korea University Anam Hospital75
招募中
不适用
Prognostic Value of Plasma Galectin-3 Concentrations for Cardiovascular Events in Patients with Heart Failure with Normal Left Ventricular Ejection FractioHeart failure with normal left ventricular ejection fractionJPRN-UMIN000014811Kumamoto University Graduate School of Medical Sciences500
已完成
不适用
"Galectin-3 as a Marker of Subclinical Inflammation in FMF"Ailesel Akdeniz AteşiNCT06451471Turkish League Against Rheumatism154